OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. Multiple strategies can be employed maximize antibody titer, including process parameter optimization, media optimization, and implementation of perfusion systems. Fine-tuning media composition plays